Biotech | August 10, 2021
INNOVIO QoQ revenues down for the period ended June 30, 2021
Company working on COVID vaccine INO 4800
Company working on COVID vaccine INO 4800
Deal signed with AOP Orphan for US commercial rights
It leverages Kite’s Chimeric Antigen Receptors and Appia Bio’s Allogeneic Cell Technology Platform to Develop Off-the-Shelf Cell Therapies
Founded in 2019, the start-up develops digital therapeutics, a therapeutic intervention from the convergence of biology and information technology
The company posted net profit of Rs.34.24 crores for the period ended June 30, 2020.
Filing for WHO Emergency Use Authorisation this month
Board declares interim dividend of Rs 2 per equity share
Board approves fundraise of Rs 1500 crore
The company expects revenue growth of 10-15 per cent in the US
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
